Literature DB >> 32037107

Allergic Endotypes and Phenotypes of Asthma.

Nicole Akar-Ghibril1, Thomas Casale2, Adnan Custovic3, Wanda Phipatanakul4.   

Abstract

Allergic asthma is defined as asthma associated with sensitization to aeroallergens, which leads to asthma symptoms and airway inflammation. Allergic asthma is the most common asthma phenotype. The onset of allergic asthma is most often in childhood and is usually accompanied by other comorbidities including atopic dermatitis and allergic rhinitis. It is often persistent although there is a wide variation in disease severity. It is a TH2-driven process. Biomarkers have been identified to distinguish patients with allergic asthma, particularly serum IgE levels, tests to indicate sensitization to aeroallergens such as specific IgE or skin prick test positivity, blood and sputum eosinophil levels, fraction of exhaled nitric oxide, and periostin. Treatments for allergic asthma include environmental control measures, allergen immunotherapy, and glucocorticoids. Biologics, targeting the TH2 pathway, have been shown to be effective in the treatment of allergic asthma.
Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergic asthma; Allergic endotypes; Allergic phenotype; Asthma; Biomarkers

Mesh:

Substances:

Year:  2020        PMID: 32037107      PMCID: PMC7569362          DOI: 10.1016/j.jaip.2019.11.008

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  105 in total

1.  A clinical index to define risk of asthma in young children with recurrent wheezing.

Authors:  J A Castro-Rodríguez; C J Holberg; A L Wright; F D Martinez
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

Review 2.  Untangling asthma phenotypes and endotypes.

Authors:  I Agache; C Akdis; M Jutel; J C Virchow
Journal:  Allergy       Date:  2012-05-17       Impact factor: 13.146

3.  Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis.

Authors:  Helen L Petsky; Chris J Cates; Kayleigh M Kew; Anne B Chang
Journal:  Thorax       Date:  2018-06-01       Impact factor: 9.139

4.  Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study.

Authors:  Leif Bjermer; Catherine Lemiere; Jorge Maspero; Sivan Weiss; James Zangrilli; Matthew Germinaro
Journal:  Chest       Date:  2016-04-04       Impact factor: 9.410

5.  Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody.

Authors:  Philip E Silkoff; Francisco A Romero; Niroo Gupta; Robert G Townley; Henry Milgrom
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

6.  Induced sputum cell count and cytokine profile in atopic and non-atopic children with asthma.

Authors:  G Vizmanos-Lamotte; A Moreno-Galdó; X Muñoz; S Gómez-Ollés; S Gartner; M J Cruz
Journal:  Pediatr Pulmonol       Date:  2013-02-08

7.  A new framework for the interpretation of IgE sensitization tests.

Authors:  G Roberts; M Ollert; R Aalberse; M Austin; A Custovic; A DunnGalvin; P A Eigenmann; F Fassio; C Grattan; P Hellings; J Hourihane; E Knol; A Muraro; N Papadopoulos; A F Santos; S Schnadt; K Tzeli
Journal:  Allergy       Date:  2016-08-15       Impact factor: 13.146

Review 8.  Biomarkers and severe asthma: a critical appraisal.

Authors:  Alessandra Chiappori; Laura De Ferrari; Chiara Folli; Pierluigi Mauri; Anna Maria Riccio; Giorgio Walter Canonica
Journal:  Clin Mol Allergy       Date:  2015-10-01

Review 9.  Blood Biomarkers of Sensitization and Asthma.

Authors:  Hans-Joachim Sonntag; Sarah Filippi; Spyros Pipis; Adnan Custovic
Journal:  Front Pediatr       Date:  2019-06-19       Impact factor: 3.418

Review 10.  Potential new targets for drug development in severe asthma.

Authors:  Linda Zhu; Christina E Ciaccio; Thomas B Casale
Journal:  World Allergy Organ J       Date:  2018-10-25       Impact factor: 4.084

View more
  28 in total

1.  Mouse Models of Asthma: Characteristics, Limitations and Future Perspectives on Clinical Translation.

Authors:  Tolga Akkoc; Liam O'Mahony; Ruth Ferstl; Cezmi Akdis; Tunc Akkoc
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  The Role of Secreted Frizzled-related Protein-1 in Allergic Asthma.

Authors:  Nooralam Rai; Emilio Arteaga-Solis; Monica Goldklang; Tina Zelonina; Jeanine D'Armiento
Journal:  Am J Respir Cell Mol Biol       Date:  2022-03       Impact factor: 6.914

Review 3.  Aeroallergens in Atopic Dermatitis and Chronic Urticaria.

Authors:  Albert C Chong; Won Jong Chwa; Peck Y Ong
Journal:  Curr Allergy Asthma Rep       Date:  2022-04-01       Impact factor: 4.806

Review 4.  Biologics to Treat Severe Asthma in Children and Adolescents: A Practical Update.

Authors:  Gian Luigi Marseglia; Amelia Licari; Maria Angela Tosca; Giorgio Ciprandi
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2020-11-13       Impact factor: 0.885

5.  Characterization of fungal exposure and dectin-1 expression in healthy horses and horses with severe asthma.

Authors:  Rebecca Di Pietro; Valérie Dubuc; Estelle Manguin; Roxane Giroux-Lafond; Christian Bédard; Roxane Boivin; Jean-Pierre Lavoie; Stephen J Vesper; Mathilde Leclere
Journal:  Am J Vet Res       Date:  2022-05-08       Impact factor: 1.055

6.  Plasma P-Selectin Is Inversely Associated with Lung Function and Corticosteroid Responsiveness in Asthma.

Authors:  Mats W Johansson; Brandon M Grill; Karina T Barretto; Molly C Favour; Hazel M Schira; Calvin M Swanson; Kristine E Lee; Ronald L Sorkness; Deane F Mosher; Loren C Denlinger; Nizar N Jarjour
Journal:  Int Arch Allergy Immunol       Date:  2020-08-10       Impact factor: 2.749

7.  Treatable Mechanisms in Asthma.

Authors:  Mario Cazzola; Josuel Ora; Francesco Cavalli; Paola Rogliani; Maria Gabriella Matera
Journal:  Mol Diagn Ther       Date:  2021-02-11       Impact factor: 4.074

8.  Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness.

Authors:  Denisa Ferastraoaru; Golda Hudes; Elina Jerschow; Sunit Jariwala; Merhunisa Karagic; Gabriele de Vos; David Rosenstreich; Manish Ramesh
Journal:  J Allergy Clin Immunol Pract       Date:  2021-01-23

Review 9.  Biomarkers for Severe Asthma: Lessons From Longitudinal Cohort Studies.

Authors:  Youngsoo Lee; Quang Luu Quoc; Hae Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2021-05       Impact factor: 5.764

10.  Asthma in children and adolescents: the ControL'Asma project.

Authors:  Amelia Licari; Giorgio Ciprandi; Gian Luigi Marseglia; Michela Silvestri; Maria Angela Tosca; Elisa Anastasio; Ilaria Brambilla; Carlo Caffarelli; Riccardo Castagnoli; Loredana Chini; Riccardo Ciprandi; Valentina De Vittori; Marzia Duse; Maria Elisa Di Cicco; Luciana Indinnimeo; Ahmad Kantar; Maddalena Leone; Guido Marinelli; Viviana Moschese; Roberta Olcese; Diego G Peroni; Angela Pistorio; Claudia Salmaso; Anna Maria Zicari
Journal:  Acta Biomed       Date:  2020-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.